Navigation Links
International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases
Date:3/18/2009

NEW YORK, March 18 /PRNewswire-USNewswire/ -- The International Trachoma Initiative (ITI) and the Task Force for Child Survival and Development announced today that they will join forces to leverage resources and scale up efforts to eliminate blinding trachoma. Trachoma, a Neglected Tropical Disease (NTD) that is the world's leading cause of preventable blindness, affects 41 million people in 56 countries. While trachoma can be prevented and cured, an estimated 6.8 million people have already lost some or all of their sight to trachoma, and an additional 8.2 million people are at risk of irreversible blindness.

"ITI is excited by the enormous potential that this merger brings to eliminating blinding trachoma," said Ibrahim Jabr, ITI President. "We realized in 2006 that to increase the impact of global trachoma control efforts, ITI would need a complementary partner to help us meet the WHO goal of elimination by 2020. We are confident that the Task Force is that partner."

ITI was created in 1998 through a public-private partnership of the Edna McConnell Clark Foundation and Pfizer, and since then, has been the only global organization dedicated exclusively to the elimination of blinding trachoma.

"Pfizer is confident that the merger between ITI and the Task Force is a positive step forward in ridding the world of blinding trachoma. Pfizer is pleased with the progress we have made with our partners over the last ten years -- providing over a billion dollars of pharmaceutical and financial donations -- that has helped break the cycle of poverty trachoma imposes on millions of families and communities world-wide. We look forward to continuing our support and working through ITI and its Trachoma Expert Committee to provide the Zithromax that will be needed to eliminate blinding trachoma by 2020 and restore the health and well-being of families now and generations to come," said Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer Inc.

"The mission and goals of ITI are a strong complement to the Task Force mission," stated Mark Rosenberg, M.D., Executive Director of the Task Force. "We are at an important juncture for trachoma control efforts and this commitment from Pfizer to supply Zithromax will help mobilize the partners essential to the success of this mission."

ITI is a major proponent and facilitator of the SAFE strategy to prevent, treat and ultimately eliminate blinding trachoma through Surgery, Antibiotics, Facial cleanliness, and Environmental improvements. The Atlanta-based Task Force, working with CARE USA, provides a forum for sharing knowledge and expertise in these four program areas, especially in the area of integration of mass drug administration, sanitation and safe water, and houses programs that address onchocerciasis (river blindness), lymphatic filariasis (elephantiasis), and intestinal worms -- three NTDs whose prevention and treatment could be linked to trachoma control.


'/>"/>
SOURCE The International Trachoma Initiative (ITI)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: